Bollywood has remained to surround the male led biasness that decides the success of any film. But, quite truly Kangana Ranaut, the Queen of Bollywood has broken such orthodox belief and trend as well. She has been delivering some of the finest films that have actually tasted success without a major male lead.
This time, she has once again proved to be a lady with an iron sword. Soon after the success of Manikarnika, she has closed her latest deal that makes her the top earning actress of Bollywood.
Kangana Ranaut has created her well recognized supremacy in Bollywood and the recent development in this regard definitely hints her long survived establishment in the industry.
The Manikarnika actress will be paid a green amount of Rs. 24 crore for her upcoming film which is a biopic on the veteran politician, Jayalalithaa. This development of hers is going to make her the highest paid Bollywood actress till date. As per the upcoming media reports from the sources, it was highlighted that, “Kangana is being paid to the tune of Rs 24 crore for the bilingual project, which will be made in Hindi and Tamil. The makers are sure that her star power will help reach a pan-India audience. Whenever Hindi artistes have done South movies, they have always shared screen space with a top star from the region. But the Manikarnika heroine will be leading from the front as the movie revolves around her character’s journey. The producers have already signed a contract with her.”
Kangana has already announced about this upcoming project on the occasion of her 32nd birthday. The biopic will be titled as Thalaivi in Tamil and named Jaya for the Hindi version. Kangana even officially announced her excitement about the project mentioning, “Jayalalithaaji is one of the biggest female success stories of this century. She was a superstar and went on to become an iconic politician, it’s a great concept for a mainstream film. I am honoured to be a part of this mega project.”
The biopic will be directed by AL Vijay, written by KV Vijayendra Prasad.